Innovative Non-antibiotic Strategies for Combating Methicillin-Resistant Staphylococcus aureus in Diabetic Foot Infections
Authors:
- 14 July 2025
- journal article
- review article
- Published by Springer Nature in Current Microbiology
- Vol. 82 (9) , 1-12
Abstract
Diabetic foot infections (DFIs) are a common and serious complication of diabetes mellitus (DM), often caused by methicillin-resistant Staphylococcus aureus (MRSA), which is challenging to treat due to its antibiotic resistance. The ability of MRSA to form biofilms and its resistance to commonly used antibiotics, such as beta-lactams, clindamycin, and trimethoprim–sulfamethoxazole, complicate treatment strategies. The pathophysiology of MRSA in DFIs involves bacterial virulence factors, including adhesion proteins, exotoxins, and immune evasion mechanisms, which allow MRSA to persist in infected wounds despite compromised immune responses in diabetic patients. Diabetes-related conditions such as neuropathy, poor glycemic control, and ischemia further exacerbate the susceptibility to and severity of these infections. With conventional antibiotic therapies facing increasing resistance, alternative non-antibiotic treatment options, including antimicrobial peptides, bacteriophage therapy, and nanotechnology-based interventions, are emerging as promising strategies. This review evaluates these alternative approaches, examining their potential to improve patient outcomes and combat antibiotic-resistant MRSA in DFIs.Keywords
This publication has 99 references indexed in Scilit:
- Novel antimicrobial strategies for diabetic foot infections: addressing challenges and resistanceActa Diabetologica, 2025
- Dual‐Mechanism Peptide SR25 has Broad Antimicrobial Activity and Potential Application for Healing Bacteria‐infected Diabetic WoundsAdvanced Science, 2024
- Narrative review on nanoparticles based on current evidence: therapeutic agents for diabetic foot infectionNaunyn-Schmiedeberg's Archives of Pharmacology, 2024
- A Smart Stimulation–Deadhesion and Antimicrobial Hydrogel for Repairing Diabetic Wounds Infected with Methicillin‐Resistant Staphylococcus aureusAdvanced Healthcare Materials, 2023
- Antibiotic Resistance Crisis: An Update on Antagonistic Interactions between Probiotics and Methicillin-Resistant Staphylococcus aureus (MRSA)Current Microbiology, 2021
- Virulence factors and clonal diversity of Staphylococcus aureus in colonization and wound infection with emphasis on diabetic foot infectionEuropean Journal of Clinical Microbiology & Infectious Diseases, 2020
- Intracellular Antimicrobial Peptides Targeting the Protein Synthesis Machinery2019
- Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fieldsJournal of Basic Microbiology, 2018
- Human Antimicrobial Peptides in Bodily Fluids: Current Knowledge and Therapeutic Perspectives in the Postantibiotic EraMedicinal Research Reviews, 2017
- Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesityCell and tissue research, 2008